AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (November 23, 2004). doi:10.1152/ajpendo.00444.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/4/E685    most recent
00444.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toth, M. J.
Right arrow Articles by Le Winter, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toth, M. J.
Right arrow Articles by Le Winter, M. M.
Submitted on September 17, 2004
Accepted on November 18, 2004

Skeletal muscle myofibrillar protein metabolism in heart failure: Relationship to immune activation and functional capacity

Michael J. Toth1*, Dwight E. Matthews1, Philip A. Ades1, Marc D. Tischler1, Peter Van Buren1, Michael Previs1, and Martin M. Le Winter1

1 Department of Medicine, University of Vermont, Burlington, VT, USA

* To whom correspondence should be addressed. E-mail: michael.toth{at}uvm.edu.

Chronic heart failure is characterized by changes in skeletal muscle that contribute to physical disability. Most studies to date have investigated defects in skeletal muscle oxidative capacity. In contrast, less is known about how heart failure affects myofibrillar protein metabolism. Thus, we examined the effect of heart failure on skeletal muscle myofibrillar protein metabolism, with a specific emphasis on changes in myosin heavy chain (MHC) protein content, synthesis and isoform distribution, in 10 patients with heart failure (mean ± SE; 63 ± 3 yrs) and 11 controls (70 ± 3 yrs). In addition, we examined the relationship of MHC protein metabolism to inflammatory markers and physical function. Although MHC and actin protein content did not differ between groups, MHC protein content decreased with increasing disease severity in heart failure patients (r =-0.748; P<0.02); whereas, actin protein content was not related to disease severity. No difference in MHC protein synthesis was found between groups and MHC protein synthesis rates were not related to disease severity. There were, however, relationships between C-reactive protein and both MHC protein synthesis (r =-0.442; P=0.05) and the ratio of MHC-to-mixed muscle protein synthesis (r=-0.493; P<0.03). Heart failure patients showed reduced relative amounts of MHC I (P<0.05) and a trend towards increased MHC IIx (P=0.06). In regression analyses, decreased MHC protein content was related to decreased exercise capacity and muscle strength in heart failure patients. Our results demonstrate that heart failure affects both the quantity and isoform distribution of skeletal muscle MHC protein. The fact that MHC protein content was related to both exercise capacity and muscle strength further suggests that quantitative alterations in MHC protein may have functional significance.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
Y. Okada, M. J. Toth, and P. VanBuren
Skeletal muscle contractile protein function is preserved in human heart failure
J Appl Physiol, April 1, 2008; 104(4): 952 - 957.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. M. W. Petersen, F. Magkos, P. Atherton, A. Selby, K. Smith, M. J. Rennie, B. K. Pedersen, and B. Mittendorfer
Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E843 - E848.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Liguzinski and B. Korzeniewski
Oxygen delivery by blood determines the maximal VO2 and work rate during whole body exercise in humans: in silico studies
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H343 - H353.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. J. Toth, P. A. Ades, M. M. LeWinter, R. P. Tracy, and A. Tchernof
Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones
J Appl Physiol, January 1, 2006; 100(1): 35 - 41.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. Szentesi, M. A. Bekedam, B. J. van Beek-Harmsen, W. J. van der Laarse, R. Zaremba, A. Boonstra, F. C. Visser, and G. J. M. Stienen
Depression of force production and ATPase activity in different types of human skeletal muscle fibers from patients with chronic heart failure
J Appl Physiol, December 1, 2005; 99(6): 2189 - 2195.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.